Li Chen

Li Chen


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2021 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
KHKeqian Hong
Keqian Hong
LCLi Chen
Li Chen
HGHui Gu
Hui Gu
XZXiumei Zhang
Xiumei Zhang
Chen JiaoChen Jiao
Chen Jiao
DYDe-Bao Yuan
De-Bao Yuan

1 January 2012 in Prostaglandins, Leukotrienes and Essential Fatty Acids
Verified
Journal Article
Closed access
RSRuihui Shan
Ruihui Shan
LCLi Chen
Li Chen
XLXin-Yu Li
Xin-Yu Li
HWHong Wu
Hong Wu
QLQingcheng Liang
Qingcheng Liang
XTXiaobo Tang
Xiaobo Tang

12 December 2024 in Life Sciences
Verified
Journal Article
Closed access
MLMengnan Liu
Mengnan Liu
BLBinru Li
Binru Li
ZYZhixue Yin
Zhixue Yin
LYLu Yin
Lu Yin
YLYe Luo
Ye Luo
LCLi Chen
Li Chen

30 August 2025 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
HCHongmei Hongmei Chen
Hongmei Hongmei Chen
KXKaimin Xiao
Kaimin Xiao
XYXinwei Yang
Xinwei Yang
ZYZhixue Yin
Zhixue Yin
YWYujie Wu
Yujie Wu
LCLi Chen
Li Chen

28 August 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
MLMengnan Liu
Mengnan Liu
ZYZhixue Yin
Zhixue Yin
BLBinru Li
Binru Li
JQJi Qiu
Ji Qiu
DZDechou Zhang
Dechou Zhang
LCLi Chen
Li Chen
Background: Cerebral ischemia‐reperfusion injury (CIRI) arises after blood flow restoration in stroke, where reperfusion paradoxically triggers mitochondrial dysfunction, apoptosis, inflammation, and oxidative stress. Dynamin‐related protein 1 (Drp1), a regulator of mitochondrial fission, amplifies these cascades by promoting apoptosis, inflammatory signaling, and calcium imbalance.Methods: This review synthesizes recent studies on Drp1 in CIRI, focusing on its regulatory roles in mitochondrial dynamics and neuronal injury, and evaluating therapeutic strategies through pharmacological and genetic modulation.Results: Evidence shows Drp1 inhibition mitigates CIRI in preclinical models by restoring mitochondrial homeostasis, reducing oxidative stress, and improving neuronal survival. Promising interventions include selective inhibitors and genetic approaches, though challenges remain regarding drug specificity, delivery efficiency, and long‐term safety.Conclusion: Drp1 is central to CIRI pathology and represents a promising therapeutic target. Future work should prioritize advanced delivery systems and safer, more selective Drp1 modulators to enable clinical translation.

7 July 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
QLQujing Liu
Qujing Liu
CZChuanfang Zhao
Chuanfang Zhao
JHJincheng Huang
Jincheng Huang
LCLi Chen
Li Chen
KYKunhao Yang
Kunhao Yang
YHYuJian He
YuJian He
In this paper, enantioselectivities of D-amino acid oxidase (DAAO) in ten ionic liquids were investigated in detail. Among the ionic liquids studied, 3-methylimidazolium formate ([MIM][COO]) was able to trigger enzyme activation with L-Ala as substrate. The enzyme activity of DAAO reached a maximum of 4.26 U mg−1 min−1 in the presence of 40% [MIM][COO], while no activity toward L-Ala was observed when DAAO was incubated with other ILs. Moreover, DAAO activities towards other L-amino acids such as L-Pro and L-Arg were also improved in [MIM][COO], which indicated that the enzymatic enantioselectivity of amino acids was lowered. This was further confirmed by capillary electrophoresis, circular dichrosim and fluorescence analysis. Molecular optimization supported that the protein–ionic liquid interactions modulated the structure of the enzyme, especially in [MIM][COO], leading to relaxation in the enantioselectivity of DAAO. This observation and exploration might open a new window for modulation enantioselectivity resolution in ionic liquids.